vs
GE医疗(CCRN)与Ribbon Communications Inc.(RBBN)财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是Ribbon Communications Inc.的1.5倍($236.8M vs $162.6M),Ribbon Communications Inc.净利率更高(54.8% vs -35.0%,领先89.8%),Ribbon Communications Inc.同比增速更快(-10.3% vs -23.6%),过去两年Ribbon Communications Inc.的营收复合增速更高(-8.1% vs -21.0%)
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业,品牌标识为GE HealthCare。公司主要业务分为四大板块:包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务,以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务,此外还开展医药相关业务。
睿宾通信公司(Ribbon Communications Inc.)主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立,总部位于美国得克萨斯州普莱诺,是一家上市科技企业。
CCRN vs RBBN — 直观对比
营收规模更大
CCRN
是对方的1.5倍
$162.6M
营收增速更快
RBBN
高出13.3%
-23.6%
净利率更高
RBBN
高出89.8%
-35.0%
两年增速更快
RBBN
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $236.8M | $162.6M |
| 净利润 | $-82.9M | $89.1M |
| 毛利率 | — | 42.9% |
| 营业利润率 | -30.2% | 37.6% |
| 净利率 | -35.0% | 54.8% |
| 营收同比 | -23.6% | -10.3% |
| 净利润同比 | -2109.7% | — |
| 每股收益(稀释后) | $-2.56 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CCRN
RBBN
| Q1 26 | — | $162.6M | ||
| Q4 25 | $236.8M | $227.3M | ||
| Q3 25 | $250.1M | $215.4M | ||
| Q2 25 | $274.1M | $220.6M | ||
| Q1 25 | $293.4M | $181.3M | ||
| Q4 24 | $309.9M | $251.4M | ||
| Q3 24 | $315.1M | $210.2M | ||
| Q2 24 | $339.8M | $192.6M |
净利润
CCRN
RBBN
| Q1 26 | — | $89.1M | ||
| Q4 25 | $-82.9M | — | ||
| Q3 25 | $-4.8M | $-12.1M | ||
| Q2 25 | $-6.7M | $-11.1M | ||
| Q1 25 | $-490.0K | $-26.2M | ||
| Q4 24 | $-3.8M | — | ||
| Q3 24 | $2.6M | $-13.4M | ||
| Q2 24 | $-16.1M | $-16.8M |
毛利率
CCRN
RBBN
| Q1 26 | — | 42.9% | ||
| Q4 25 | — | 53.3% | ||
| Q3 25 | 20.4% | 50.1% | ||
| Q2 25 | 20.4% | 49.6% | ||
| Q1 25 | 20.0% | 45.4% | ||
| Q4 24 | — | 55.7% | ||
| Q3 24 | 20.4% | 52.1% | ||
| Q2 24 | 20.8% | 50.8% |
营业利润率
CCRN
RBBN
| Q1 26 | — | 37.6% | ||
| Q4 25 | -30.2% | 4.1% | ||
| Q3 25 | -2.4% | 1.3% | ||
| Q2 25 | -2.1% | 1.9% | ||
| Q1 25 | -0.3% | -10.8% | ||
| Q4 24 | -1.1% | 13.2% | ||
| Q3 24 | 0.9% | -0.4% | ||
| Q2 24 | -5.7% | -1.0% |
净利率
CCRN
RBBN
| Q1 26 | — | 54.8% | ||
| Q4 25 | -35.0% | — | ||
| Q3 25 | -1.9% | -5.6% | ||
| Q2 25 | -2.4% | -5.0% | ||
| Q1 25 | -0.2% | -14.5% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 0.8% | -6.4% | ||
| Q2 24 | -4.7% | -8.7% |
每股收益(稀释后)
CCRN
RBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | $-2.56 | $0.50 | ||
| Q3 25 | $-0.15 | $-0.07 | ||
| Q2 25 | $-0.20 | $-0.06 | ||
| Q1 25 | $-0.02 | $-0.15 | ||
| Q4 24 | $-0.13 | $0.05 | ||
| Q3 24 | $0.08 | $-0.08 | ||
| Q2 24 | $-0.47 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $67.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $322.8M | $419.1M |
| 总资产 | $449.0M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CCRN
RBBN
| Q1 26 | — | $67.6M | ||
| Q4 25 | $108.7M | $96.4M | ||
| Q3 25 | $99.1M | $74.8M | ||
| Q2 25 | $81.2M | $60.5M | ||
| Q1 25 | $80.7M | $71.2M | ||
| Q4 24 | $81.6M | $87.8M | ||
| Q3 24 | $64.0M | $37.2M | ||
| Q2 24 | $69.6M | $64.6M |
总债务
CCRN
RBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | — | $344.3M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $347.4M | ||
| Q4 24 | — | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M |
股东权益
CCRN
RBBN
| Q1 26 | — | $419.1M | ||
| Q4 25 | $322.8M | $449.0M | ||
| Q3 25 | $408.1M | $360.1M | ||
| Q2 25 | $412.2M | $370.4M | ||
| Q1 25 | $418.2M | $381.8M | ||
| Q4 24 | $419.0M | $404.6M | ||
| Q3 24 | $424.7M | $395.5M | ||
| Q2 24 | $433.3M | $405.0M |
总资产
CCRN
RBBN
| Q1 26 | — | — | ||
| Q4 25 | $449.0M | $1.2B | ||
| Q3 25 | $538.2M | $1.1B | ||
| Q2 25 | $553.8M | $1.1B | ||
| Q1 25 | $576.2M | $1.1B | ||
| Q4 24 | $589.3M | $1.2B | ||
| Q3 24 | $597.4M | $1.1B | ||
| Q2 24 | $602.9M | $1.1B |
负债/权益比
CCRN
RBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $18.2M | — |
| 自由现金流经营现金流 - 资本支出 | $16.1M | — |
| 自由现金流率自由现金流/营收 | 6.8% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $40.1M | — |
8季度趋势,按日历期对齐
经营现金流
CCRN
RBBN
| Q1 26 | — | — | ||
| Q4 25 | $18.2M | $29.2M | ||
| Q3 25 | $20.1M | $26.5M | ||
| Q2 25 | $4.2M | $-795.0K | ||
| Q1 25 | $5.7M | $-3.5M | ||
| Q4 24 | $24.2M | $61.8M | ||
| Q3 24 | $7.5M | $-14.8M | ||
| Q2 24 | $82.4M | $-9.8M |
自由现金流
CCRN
RBBN
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | $27.3M | ||
| Q3 25 | $17.9M | $21.0M | ||
| Q2 25 | $2.3M | $-6.5M | ||
| Q1 25 | $3.8M | $-15.7M | ||
| Q4 24 | $21.7M | $53.8M | ||
| Q3 24 | $6.3M | $-23.7M | ||
| Q2 24 | $79.6M | $-12.9M |
自由现金流率
CCRN
RBBN
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 12.0% | ||
| Q3 25 | 7.2% | 9.7% | ||
| Q2 25 | 0.8% | -2.9% | ||
| Q1 25 | 1.3% | -8.7% | ||
| Q4 24 | 7.0% | 21.4% | ||
| Q3 24 | 2.0% | -11.3% | ||
| Q2 24 | 23.4% | -6.7% |
资本支出强度
CCRN
RBBN
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 0.9% | ||
| Q3 25 | 0.9% | 2.6% | ||
| Q2 25 | 0.7% | 2.6% | ||
| Q1 25 | 0.6% | 6.7% | ||
| Q4 24 | 0.8% | 3.2% | ||
| Q3 24 | 0.4% | 4.2% | ||
| Q2 24 | 0.8% | 1.6% |
现金转化率
CCRN
RBBN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |